Boston Trust Walden Corp Sells 10,023 Shares of CorVel Co. (NASDAQ:CRVL)

Boston Trust Walden Corp decreased its holdings in shares of CorVel Co. (NASDAQ:CRVL) by 4.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 232,515 shares of the business services provider’s stock after selling 10,023 shares during the period. Boston Trust Walden Corp owned 1.35% of CorVel worth $76,007,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Janus Henderson Group PLC raised its position in shares of CorVel by 997.8% in the 1st quarter. Janus Henderson Group PLC now owns 46,975 shares of the business services provider’s stock worth $12,351,000 after purchasing an additional 42,696 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in CorVel by 41.8% in the second quarter. Assenagon Asset Management S.A. now owns 115,876 shares of the business services provider’s stock worth $29,464,000 after buying an additional 34,155 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its stake in shares of CorVel by 1.1% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,925,635 shares of the business services provider’s stock worth $489,631,000 after buying an additional 21,673 shares in the last quarter. Sei Investments Co. grew its holdings in shares of CorVel by 65.8% during the first quarter. Sei Investments Co. now owns 21,003 shares of the business services provider’s stock valued at $5,523,000 after buying an additional 8,338 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D bought a new stake in shares of CorVel during the second quarter valued at approximately $1,937,000. 51.36% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director R Judd Jessup sold 2,500 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $311.60, for a total transaction of $779,000.00. Following the transaction, the director now directly owns 40,777 shares of the company’s stock, valued at $12,706,113.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other CorVel news, CFO Brandon O’brien sold 1,000 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $314.98, for a total value of $314,980.00. Following the transaction, the chief financial officer now directly owns 6,502 shares in the company, valued at approximately $2,047,999.96. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director R Judd Jessup sold 2,500 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $311.60, for a total transaction of $779,000.00. Following the sale, the director now directly owns 40,777 shares of the company’s stock, valued at approximately $12,706,113.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 19,893 shares of company stock valued at $6,003,958. Company insiders own 47.57% of the company’s stock.

CorVel Price Performance

Shares of CorVel stock traded down $0.09 during trading on Friday, hitting $304.01. 14,344 shares of the company’s stock traded hands, compared to its average volume of 36,450. CorVel Co. has a 1 year low of $187.92 and a 1 year high of $329.23. The business has a 50-day simple moving average of $313.50 and a 200-day simple moving average of $280.26. The stock has a market capitalization of $5.22 billion, a P/E ratio of 69.09 and a beta of 1.08.

CorVel (NASDAQ:CRVL) last announced its quarterly earnings results on Tuesday, July 30th. The business services provider reported $1.25 earnings per share (EPS) for the quarter. CorVel had a net margin of 9.55% and a return on equity of 32.25%. The firm had revenue of $211.72 million for the quarter.

Analysts Set New Price Targets

Separately, StockNews.com downgraded CorVel from a “buy” rating to a “hold” rating in a research note on Saturday, August 31st.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.